Aequus Pharmaceuticals Inc.
AQS.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.17M | -1.56M | -1.60M | -1.97M | -2.12M |
| Total Depreciation and Amortization | 71.00K | 95.20K | 96.60K | 97.90K | 99.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 363.80K | 377.20K | 54.70K | 72.10K | 79.20K |
| Change in Net Operating Assets | 415.30K | 276.30K | 229.90K | -24.60K | -113.60K |
| Cash from Operations | -324.30K | -806.40K | -1.22M | -1.82M | -2.05M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.00K | 32.00K | 32.00K | -- | -- |
| Cash from Investing | 32.00K | 32.00K | 32.00K | -- | -- |
| Total Debt Issued | 473.50K | 1.02M | 1.66M | 2.56M | 2.96M |
| Total Debt Repaid | -84.10K | -168.80K | -167.90K | -165.40K | -162.10K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 285.60K | 626.00K | 1.10M | 1.76M | 2.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 110.70K | -1.60K | -1.60K | -1.60K |
| Net Change in Cash | -6.70K | -37.70K | -89.10K | -64.00K | 10.60K |